Betagistin – Tagista tablets 24 mg 30 pcs

$16.00

Description

Description

tablets almost white or white with Valium Valium a color shade with a facet and Valium.

release form

Tablets

packaging 30 pcs

Pharmacological action

A drug that improves the microcirculation of the labyrinth, used in the pathology of the vestibular apparatus. Betagistin acts mainly on the histamine H1 and H3 receptors of the inner ear and vestibular nuclei of the central nervous system.

By direct agonistic action on the histamine H1 receptors of the vessels of the inner ear, and also indirectly through exposure to histamine H3 receptors improves microcirculation and capillary permeability, normalizes endolymph pressure in the labyrinth and cochlea. However, betahistine increases blood flow in the basilar artery.

Has a pronounced central effect, being an inhibitor of histamine H3 receptors of the vestibular nerve nuclei. Normalizes conduction in neurons inestibular nuclei at the level of the brain stem.

The clinical manifestation of these properties is a decrease in the frequency and intensity of dizziness, less tinnitus, better hearing in

Indications

treatment and prevention of vestibular dizziness of various origins: syndromes including dizziness and headache, tinnitus, progressive hearing loss, nausea and vomiting: M “ ©ni “ re’s disease or syndrome.

Use during pregnancy and lactation

Contraindication: age up to 18 years (due to lack of data).

Due to the lack of data, the drug is contraindicated in pregnancy and lactation.

Composition

1 tablet contains Active ingredient: betahistine dihydrochloride 24.0 mg Excipients: microcrystalline cellulose – 64.25 mg, povidone (collidone 25) – 27.0 mg potato starch – 60.0 mg, citric acid – 6, 0 mg, colloidal silicon dioxide (Aerosil), – 9.0 mg, talc – / 8.4 mg, magnesium stearate – / 1.35 mg.

Dosage and Administration

Inside, with meals. 24 mg tablets: 1 tablet 2 times a day. Improvement is usually noted already at the beginning of therapy, a stable therapeutic effect occurs after two weeks of treatment and can increase over several months of treatment. The treatment is long. The duration of treatment is determined individually.

Side effects

Gastrointestinal upset. the appearance of hypersensitivity reactions from the skin (rash, itching, urticaria), Quincke’s edema.

Overdose

Symptoms: nausea, vomiting, convulsions.

Treatment: gastric lavage, activated carbon intake, symptomatic therapy.

Storage Conditions

In a dry, dark place at a temperature not exceeding 25 ° C. Keep out of reach of children.

Shelf life

3 years. Do not use after the expiration date indicated on the package.

Deystvuyushtee substance

Betagistin

Terms and conditions otpuska from

pharmacies by prescription

Dosage form

tablets

Prescribing

Prescribing

Adults as prescribed by a doctor